Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
TAKEDA Pharmaceutical Co Ltd said that its annual profit will outstrip a prior estimate and reach a six-year high, boosted by stronger sales of the cancer drug Velcade, after earlier reporting better-than-expected quarterly earnings.
Velcade is used to treat multiple myeloma...